Sangamo Therapeutics


Sangamo Therapeutics Stock Quote
$6.72 -$0.16 -2.4%
Price as of February 27, 2020, 3:55 p.m. EST View Interactive SGMO Charts

The Company deals in the research, development and commercialization of DNA-binding proteins for the therapeutic regulation and modification of disease-related genes.

Interactive Chart

News & Analysis: Sangamo Therapeutics

The Fool has written over 100 articles on Sangamo Therapeutics.


Market Moves


What Happened in the Stock Market Today

Sangamo Therapeutics reported positive data on its gene therapy for hemophilia, and CannTrust Holdings received a noncompliance report from Canadian authorities.